375 related articles for article (PubMed ID: 18059317)
1. Region-specific effects of N,N'-dodecane-1,12-diyl-bis-3-picolinium dibromide on nicotine-induced increase in extracellular dopamine in vivo.
Rahman S; Zhang Z; Papke RL; Crooks PA; Dwoskin LP; Bardo MT
Br J Pharmacol; 2008 Feb; 153(4):792-804. PubMed ID: 18059317
[TBL] [Abstract][Full Text] [Related]
2. The effects of a novel nicotinic receptor antagonist N,N-dodecane-1,12-diyl-bis-3-picolinium dibromide (bPiDDB) on acute and repeated nicotine-induced increases in extracellular dopamine in rat nucleus accumbens.
Rahman S; Neugebauer NM; Zhang Z; Crooks PA; Dwoskin LP; Bardo MT
Neuropharmacology; 2007 Mar; 52(3):755-63. PubMed ID: 17097117
[TBL] [Abstract][Full Text] [Related]
3. The novel nicotinic receptor antagonist, N,N'-dodecane-1,12-diyl-bis-3-picolinium dibromide (bPiDDB), inhibits nicotine-evoked [(3)H]norepinephrine overflow from rat hippocampal slices.
Smith AM; Dhawan GK; Zhang Z; Siripurapu KB; Crooks PA; Dwoskin LP
Biochem Pharmacol; 2009 Oct; 78(7):889-97. PubMed ID: 19631612
[TBL] [Abstract][Full Text] [Related]
4. The novel nicotinic receptor antagonist N,N'-dodecane-1,12-diyl-bis-3-picolinium dibromide decreases nicotine-induced dopamine metabolism in rat nucleus accumbens.
Rahman S; Neugebauer NM; Zhang Z; Crooks PA; Dwoskin LP; Bardo MT
Eur J Pharmacol; 2008 Dec; 601(1-3):103-5. PubMed ID: 19000671
[TBL] [Abstract][Full Text] [Related]
5. Effect of a novel nicotinic receptor antagonist, N,N'-dodecane-1,12-diyl-bis-3-picolinium dibromide, on nicotine self-administration and hyperactivity in rats.
Neugebauer NM; Zhang Z; Crooks PA; Dwoskin LP; Bardo MT
Psychopharmacology (Berl); 2006 Mar; 184(3-4):426-34. PubMed ID: 16220336
[TBL] [Abstract][Full Text] [Related]
6. N,N'-Alkane-diyl-bis-3-picoliniums as nicotinic receptor antagonists: inhibition of nicotine-evoked dopamine release and hyperactivity.
Dwoskin LP; Wooters TE; Sumithran SP; Siripurapu KB; Joyce BM; Lockman PR; Manda VK; Ayers JT; Zhang Z; Deaciuc AG; McIntosh JM; Crooks PA; Bardo MT
J Pharmacol Exp Ther; 2008 Aug; 326(2):563-76. PubMed ID: 18460644
[TBL] [Abstract][Full Text] [Related]
7. bPiDI: a novel selective α6β2* nicotinic receptor antagonist and preclinical candidate treatment for nicotine abuse.
Wooters TE; Smith AM; Pivavarchyk M; Siripurapu KB; McIntosh JM; Zhang Z; Crooks PA; Bardo MT; Dwoskin LP
Br J Pharmacol; 2011 May; 163(2):346-57. PubMed ID: 21232049
[TBL] [Abstract][Full Text] [Related]
8. Repeated nicotine administration robustly increases bPiDDB inhibitory potency at alpha6beta2-containing nicotinic receptors mediating nicotine-evoked dopamine release.
Smith AM; Pivavarchyk M; Wooters TE; Zhang Z; Zheng G; McIntosh JM; Crooks PA; Bardo MT; Dwoskin LP
Biochem Pharmacol; 2010 Aug; 80(3):402-9. PubMed ID: 20346923
[TBL] [Abstract][Full Text] [Related]
9. Ethanol elevates accumbal dopamine levels via indirect activation of ventral tegmental nicotinic acetylcholine receptors.
Ericson M; Molander A; Löf E; Engel JA; Söderpalm B
Eur J Pharmacol; 2003 Apr; 467(1-3):85-93. PubMed ID: 12706460
[TBL] [Abstract][Full Text] [Related]
10. Nicotine withdrawal produces a decrease in extracellular levels of dopamine in the nucleus accumbens that is lower in adolescent versus adult male rats.
Natividad LA; Tejeda HA; Torres OV; O'Dell LE
Synapse; 2010 Feb; 64(2):136-45. PubMed ID: 19771590
[TBL] [Abstract][Full Text] [Related]
11. Nicotinic acetylcholine receptors in the mesolimbic pathway: primary role of ventral tegmental area alpha6beta2* receptors in mediating systemic nicotine effects on dopamine release, locomotion, and reinforcement.
Gotti C; Guiducci S; Tedesco V; Corbioli S; Zanetti L; Moretti M; Zanardi A; Rimondini R; Mugnaini M; Clementi F; Chiamulera C; Zoli M
J Neurosci; 2010 Apr; 30(15):5311-25. PubMed ID: 20392953
[TBL] [Abstract][Full Text] [Related]
12. Differential effects of nicotinic antagonists perfused into the nucleus accumbens or the ventral tegmental area on cocaine-induced dopamine release in the nucleus accumbens of mice.
Zanetti L; Picciotto MR; Zoli M
Psychopharmacology (Berl); 2007 Feb; 190(2):189-99. PubMed ID: 17061109
[TBL] [Abstract][Full Text] [Related]
13. Local alpha-bungarotoxin-sensitive nicotinic receptors in the nucleus accumbens modulate nicotine-stimulated dopamine secretion in vivo.
Fu Y; Matta SG; Gao W; Sharp BM
Neuroscience; 2000; 101(2):369-75. PubMed ID: 11074160
[TBL] [Abstract][Full Text] [Related]
14. Discovery of a novel nicotinic receptor antagonist for the treatment of nicotine addiction: 1-(3-Picolinium)-12-triethylammonium-dodecane dibromide (TMPD).
Dwoskin LP; Joyce BM; Zheng G; Neugebauer NM; Manda VK; Lockman P; Papke RL; Bardo MT; Crooks PA
Biochem Pharmacol; 2007 Oct; 74(8):1271-82. PubMed ID: 17727820
[TBL] [Abstract][Full Text] [Related]
15. Infusion of nicotine in the ventral tegmental area or the nucleus accumbens of the rat differentially affects accumbal dopamine release.
Nisell M; Nomikos GG; Svensson TH
Pharmacol Toxicol; 1994 Dec; 75(6):348-52. PubMed ID: 7534921
[TBL] [Abstract][Full Text] [Related]
16. Systemic nicotine-induced dopamine release in the rat nucleus accumbens is regulated by nicotinic receptors in the ventral tegmental area.
Nisell M; Nomikos GG; Svensson TH
Synapse; 1994 Jan; 16(1):36-44. PubMed ID: 8134899
[TBL] [Abstract][Full Text] [Related]
17. Accumbal dopamine overflow after ethanol: localization of the antagonizing effect of mecamylamine.
Blomqvist O; Ericson M; Engel JA; Söderpalm B
Eur J Pharmacol; 1997 Sep; 334(2-3):149-56. PubMed ID: 9369343
[TBL] [Abstract][Full Text] [Related]
18. Systemic nicotine stimulates dopamine release in nucleus accumbens: re-evaluation of the role of N-methyl-D-aspartate receptors in the ventral tegmental area.
Fu Y; Matta SG; Gao W; Brower VG; Sharp BM
J Pharmacol Exp Ther; 2000 Aug; 294(2):458-65. PubMed ID: 10900219
[TBL] [Abstract][Full Text] [Related]
19. Nicotine enhances responding for conditioned reinforcement via α4β2 nicotinic acetylcholine receptors in the ventral tegmental area, but not the nucleus accumbens or the prefrontal cortex.
Tabbara RI; Fletcher PJ
Neuropharmacology; 2019 Apr; 148():68-76. PubMed ID: 30550794
[TBL] [Abstract][Full Text] [Related]
20. Nicotinic acetylcholine receptors in the ventral tegmental area mediate the dopamine activating and reinforcing properties of ethanol cues.
Löf E; Olausson P; deBejczy A; Stomberg R; McIntosh JM; Taylor JR; Söderpalm B
Psychopharmacology (Berl); 2007 Dec; 195(3):333-43. PubMed ID: 17703283
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
